|
Dec. 03, 2007 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080220475 |
A randomized, double-blind, Phase II/III study of JR-013 in the patients with renal anemia receiving hemodialysis treatment |
|
| version: date: |
Kissei Pharmaceutical Co., Ltd. |
||
rinsyousiken@pharm.kissei.co.jp |
||
Interventional |
||
A randomized, double-blind, parallel group study |
||
2-3 |
||
20 Years and above, Renal anemia patients receiving hemodialysis treatment |
||
| 20age old over | ||
| No limit | ||
Both |
||
Renal anemia |
||
investigational material(s) |
||
Efficacy and Safety |
||
| KISSEI PHARMACEUTICAL CO.,LTD. | |
| JapicCTI-070485 | |